Eric Hyllengren | Vice President of Investor Relations & Finance |
Pascal Touchon | President & Chief Executive Officer |
Jakob Dupont | Executive Vice President and Global Head of Research and Development |
AJ Joshi | Chief Medical Officer |
Jose Vidal | Head of GMP Quality & Process Sciences |
John Newman | Canaccord Genuity |
Jonathan Miller | Evercore ISI |
Salim Syed | Mizuho |
Phil Nadeau | Cowen & Company |
Matt Phipps | William Blair |
Good afternoon, everyone, thank you for standing by. And welcome to the Atara Biotherapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please be advised that today's call is being recorded.